From Nasdaq: 2025-02-25 17:24:02

Masimo (NASDAQ: MASI) reported fourth-quarter earnings for 2024 on Feb. 25, 2025, showing strong performance in its healthcare segment with revenue hitting $601 million, surpassing analyst expectations of $592 million. Non-GAAP EPS was $1.80, beating both analyst forecasts and management guidance. The company is focusing on core healthcare operations following the acquisition of Sound United, realigning strategies for long-term growth opportunities. Masimo’s revenue grew by 9% year-over-year, with healthcare revenue at $368 million and non-healthcare revenue at $232 million in Q4. CEO Katie Szyman is leading the shift back to core healthcare business. Looking ahead to 2025, Masimo projects healthcare revenue of $1,500 million to $1,530 million and non-GAAP EPS of $5.10 to $5.40, emphasizing strategic realignments for profitability and shareholder value.



Read more at Nasdaq: Masimo Tops EPS, Revenue Expectations